What one share of Annexon holds
We are a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at complement-mediated neuroinflammatory diseases that impact nearly 10 million people worldwide. The classical complement pathway is a core component to the body’s immune system that activates a powerful inflammatory cascade.
Annexon’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.13 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.08 |
| Cash and investments | $0.99 |
| Book value | $0.93 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$88.30 | $0.62 | −$66.03 | — | −$231.59 |
| 2020 | — | −$4.15 | $0.03 | −$3.16 | $0.00 | — |
| 2021 | — | −$3.40 | $0.04 | −$2.81 | $0.00 | $6.01 |
| 2022 | — | −$2.60 | $0.12 | −$2.25 | $0.00 | $4.84 |
| 2023 | — | −$1.77 | $0.00 | −$1.60 | $0.00 | $3.20 |
| 2024 | — | −$1.01 | $0.00 | −$0.86 | $0.00 | $2.68 |
| 2025 | — | −$1.34 | $0.00 | −$1.20 | $0.00 | $1.42 |
Common questions about Annexon
How much does one share of Annexon earn?
Over the last 12 months, Annexon lost $1.13 for each share.
Does Annexon pay a dividend?
Annexon didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Annexon’s book value per share?
Annexon’s book value is $0.93 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Annexon have?
Each share of Annexon has $0.99 of cash and investments, as of June 30, 2026.
What is Annexon’s free cash flow per share?
−$1.08 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Annexon bought back shares?
Annexon’s share count rose about 35680% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.